<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T04:54:13Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/48746" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/48746</identifier><datestamp>2024-12-05T21:50:38Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2024-12-05T21:50:38Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_10459.1_48746">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10459.1/48746</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>In vitro bioaccessibility of health-related compounds from a blended fruit juice-soymilk beverage: Influence of the food matrix</dc:title>
               <dc:creator>Rodríguez Roque, María Janeth</dc:creator>
               <dc:creator>Rojas Grau, María Alejandra</dc:creator>
               <dc:creator>Elez Martínez, Pedro</dc:creator>
               <dc:creator>Martín Belloso, Olga</dc:creator>
               <dc:subject>Fruit juice-based beverages</dc:subject>
               <dc:subject>bioaccessibility</dc:subject>
               <dc:subject>Bioactive compounds</dc:subject>
               <dc:subject>food matrix</dc:subject>
               <dc:subject>Antioxidant activity</dc:subject>
               <dc:subject>Sucs de fruita</dc:subject>
               <dc:subject>Soia (Aliment)</dc:subject>
               <dc:subject>Vitamina C</dc:subject>
               <dc:subject>Fruit juices</dc:subject>
               <dc:subject>Soyfoods</dc:subject>
               <dc:subject>Vitamin C</dc:subject>
               <dc:description>This research evaluated the effect of an in vitro gastrointestinal digestion on the concentration of vitamin C, phenolic compounds, isoflavones, carotenoids, as well as antioxidant activity of a beverage containing a blended fruit juice and soymilk (BFJ&lt;br>SMB). Additionally, the influence of the food matrix on the bioaccessibility of these compounds was studied. BFJ&lt;br>SMB hydrophilic constituents displayed higher bioaccessibility (12&lt;br>26.5%) than those lipophilics (6.5&lt;br>13.8%). The most bioaccessible compounds were quercetin and genistein, while cis-violaxanthin+neoxanthin were the lowest. Several compounds were less bioaccessible in BFJ&lt;br>SMB (6.5&lt;br>14%) with respect to those of BFJ or SM. Conversely, phenolic acids and aglycone isoflavones displayed their highest bioaccessibility in BFJ&lt;br>SMB. Results showed that both the in vitro gastrointestinal digestion and the food matrix exerted a significant influence on the bioaccessibility of these compounds. BFJ&lt;br>SMB can be considered as a beverage with an important nutritional quality and highly bioaccessible substances.</dc:description>
               <dc:date>2024-12-05T21:50:38Z</dc:date>
               <dc:date>2024-12-05T21:50:38Z</dc:date>
               <dc:date>2015-09-23T11:20:29Z</dc:date>
               <dc:date>2015-09-23T11:20:29Z</dc:date>
               <dc:date>2025-01-01</dc:date>
               <dc:date>2014-03-01</dc:date>
               <dc:date>2015-09-23T11:20:29Z</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/10459.1/48746</dc:identifier>
               <dc:relation>Reproducció del document publicat a: https://doi.org/10.1016/j.jff.2014.01.023</dc:relation>
               <dc:relation>Journal of Functional Foods, 2014, vol. 7, p. 161-169</dc:relation>
               <dc:rights>(c) Elsevier, 2014</dc:rights>
               <dc:rights>info:eu-repo/semantics/restrictedAccess</dc:rights>
               <dc:publisher>Elsevier</dc:publisher>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>